1.      Mashima Y, Konta T, Ichikawa K, Ikeda a, Suzuki K, Wanezaki M, Nishiyama S, Watanabe T,Kubota I: Rapid decline in renal functioan after acute myocardial infarction. ClinNephrol. 2013 Jan; 79(1): 15-20

 

2.      Sato M, Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, Aida Y, Kishi H, Nunomiya K, Nakano H, Sato K, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I: Retrospective analysis of the relationship between decline in FEV(1) and abdominal circumference in male smokers: The Takahata study. Int J Med Sci. 2013; 10(1): 1-7

 

3.      Niizeki T, Takeishi Y, Sasaki T, Kaneko K, Sugawara S, Watanabe T, Kubota I: Usefulness of albuminuria as a prognostic indicator in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2013 Apr; 111(8): 1180-1186

 

4.      Suzuki S, Shishido T, Funayama A, Netsu S, Ishino M, Kitahara T, Sasaki T, Katoh S, Otaki Y, Watanabe T, Shibata Y, Mantovani A, Takeishi Y, Kubota I: Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction. PLoS One. 2013; 8(1): e53133

 

5.      Funayama A, Shishido T, Miyashita T, Netsu S, Otaki Y, Arimoto T, Takahashi H, Miyamoto T, Watanabe T, Konta T, Kubota I: Renal tubulointerstitial damage is associated with short-term cardiovascular events in patients with myocardial infarction. Circ J. 2013; 77(2): 484-489

 

6.      Kaino W, Daimon M, Sasaki S, Karasawa S, Takase K, Tada K, Wada K, Kameda W, Susa S, Oizumi T, Fukao A, Kubota I, Kayama T, Kato T: Lower physical activity is a risk factor for a clustering of metabolic risk factors in non-obese and obese Japanese subjects: The Takahata study. Endocr J. 2013 May 31; 60(5): 617-628

 

7.      JSN, JRS and JCS Joint Working Group: Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. Circ J. 2013 July; 77(7): 1883-1914

 

8.      Nunomiya K, Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, Aida Y, Kishi H, Sato M, Watanabe T, Konta T, Ueno Y, Kato T, Yamashita H, Kayama T, Kubota I: Hyperhomocysteinaemia predicts the decline in pulmonary function in healthy male smokers. Eur Respir J. 2013 Jul; 42(1): 18-27

 

9.      Otaki Y, Watanabe T, Shishido T, Takahashi H, Funayama A, Narumi T, Kadowaki S, Hasegawa H, Honda S, Netsu S, Ishino M, Arimoto T, Miyashita T, Miyamoto T,Konta T, Kubota I: The impact of renal tubular damage, as assessed by urinary β2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure. Circ Heart Fail. 2013 Jul 1; 6(4): 662-668

 

10.   Suzuki K, Konta T, Kudo K, Sato H, Ikeda A, Ichikawa K, Ueno Y, Kato T, Kayama T, Kubota I: The association between serum uric acid and renal damage in a community-based population: the Takahata study. Clin Exp Nephrol. 2013 Aug; 17(4): 541-548

 

11.   Misaka T, Suzuki S, Miyata M, Kobayashi A, Shishido T, Ishigami A, Saitoh S, Hirose M, Kubota I, Takeishi Y: Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling. Cardiovasc Res. 2013 Aug 1; 99(3): 461-470

 

12.   Inoue H, Okumura K, Atarashi H, Yamashita T, Origasa H, Kumagai N, Sakurai M, Kawamura Y, Kubota I, Matsumoto K, Kaneko Y, Ogawa S, Aizawa Y, Chinushi M, Kodama I, Watanabe E, Koretsune Y, Okuyama Y, Shimizu A, Igawa O, Bando S, Fukatani M, Saikawa T, Chishaki A; J-RHYTHM Registry Investigators: Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation. -Results of the J-RHYTHM Registry-. Circ J. 2013 Aug 23; 77(9): 2264-2270

 

13.   Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H, Komatsu Y, Tamura S, Awai K, Yamashita Y, Kuwatsuru R, Hirayama A, Saito Y, Murohara T, Tamaki N, Sato A, Takayama T, Imai E, Yasuda Y, Koya D, Tsubakihara Y, Horie S, Korogi Y, Narumi Y, Hayakawa K, Daida H, Node K, Kubota I: Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version: JSN, JRS, and JCS Joint Working Group. Clin Exp Nephrol. 2013 Aug; 17(4): 441-479

 

14.   Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H, Komatsu Y, Tamura S, Awai K, Yamashita Y, Kuwatsuru R, Hirayama A, Saito Y, Murohara T, Tamaki N, Sato A, Takayama T, Imai E, Yasuda Y, Koya D, Tsubakihara Y, Horie S, Korogi Y, Narumi Y, Hayakawa K, Daida H, Node K, Kubota I: Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version: JSN, JRS, and JCS Joint Working Group. Jpn J Radiol. 2013 Aug; 31(8): 546-584

 

15.   Funayama A, Shishido T, Netsu S, Narumi T, Kadowaki S, Takahashi H, Miyamoto T, Watanabe T, Woo CH, Abe J, Kuwahara K, Nakao K, Takeishi Y, Kubota I: Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure. Cardiovasc Res. 2013 Sep 1; 99(4): 657-664

 

16.   Narimatsu H, Kitanaka C, Kubota I, Sato S, Ueno Y, Kato T, Fukao A, Yamashita H, Kayama T; Yamagata University Medical Education and Training Program through the Genomic Cohort Study: New developments in medical education for the realization of next-generation personalized medicine: concept and design of a medical education and training program through the genomic cohort study. J Hum Genet. 2013 Sep; 58(9): 639-640

 

17.   Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, Aida Y, Kishi H, Nunomiya K, Nakano H, Sato M, Sato K, Kimura T, Nemoto T, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I: Relationship between plasma fibrinogen levels and pulmonary function in the Japanese population: the Takahata study. Int J Med Sci. 2013 Sep 1; 10(11): 1530-1536

 

18.   Sato-Nishiwaki M, Aida Y, Abe S, Shibata Y, Kimura T, Yamauchi K, Kishi H, Igarashi A, Inoue S, Sato M, Nakajima O, Kubota I: Reduced number and morphofunctional change of alveolar macrophages in MafB gene-targeted mice. PLoS One. 2013 Sep 6; 8(9): e73963

 

19.   Shibata Y, Inoue S, Igarashi A, Yamauchi K, Abe S, Aida Y, Nunomiya K, Sato M, Nakano H, Sato K, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I: Elevated serum iron is a potent biomarker for spirometric resistance to cigarette smoke among Japanese males: the Takahata study. PLoS One. 2013 Sep 9; 8(9): e74020

 

20.   Misaka T, Suzuki S, Miyata M, Kobayashi A, Ishigami A, Shishido T, Saitoh S, Kubota I, Takeishi Y: Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction. Biochem Biophys Res Commun. 2013 Sep 13; 439(1): 142-147

 

21.   Narumi T, Arimoto T, Funayama A, Kadowaki S, Otaki Y, Nishiyama S, Takahashi H, Shishido T, Miyashita T, Miyamoto T, Watanabe T, Kubota I: The prognostic importance of objective nutritional indexes in a patients with chronic heart failure. J Cardiol. 2013 Nov; 62(5): 307-313

 

22.   Otaki Y, Watanabe T, Takahashi H, Hasegawa H, Honda S, Funayama A, Netsu S, Ishino M, Arimoto T, Shishido T, Miyashita T, Miyamoto T, Konta T, Kubota I: Acidic urine is associated with poor prognosis in patients with chronic heart failure. Heart Vessels. 2013 Nov; 28(6): 735-741

 

23.   Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Abe Y, Saito T, Ohwada T, Suzuki H, Saitoh S, Kubota I, Takeishi Y; AVCMA investigators. Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitiede. J Clin Pharmacol. 2013 Dec; 53(12): 1277-1285

 

24.   Nakano H, Shibata Y, Inoue S, Agarashi A, Yamauchi K, Abe S, Masamichi S, Aida Y, Nunomiya K, Kimura T, Nemoto T, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I: Relationships between values of antibodies to several connective tissue disease autoantigens and pulmonary function in a Japanese general population: the Takahata study. PLoS One. 2013 Dec 3; 8(12): e81678

 

25.   Konta T, Kudo K, Sato H, Ichikawa K, Ikeda A, Suzuki K, Hirayama A, Shibata Y, Watanabe T, Daimon M, Kato T, Ueno Y, Kayama T, Kubota I: Albuminuria is an independent predictor of all-cause and cardiovascular mortality in the Japanese population: the Takahata study. Clin Exp Nephrol. 2013 Dec; 17(6); 805-810

 

26.   Shibata Y, Inoue S, Igarashi A, Yamauchi K, Abe S, Aida Y, Nunomiya K, Sato M, Nakano H, Sato K, Nemoto T, Kimura T, Watanabe T, Konta T, Daimon M, Ueno Y, Kato T, Kayama T, Kubota I: A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study. 2013 Dec; 8(12): e83725

 

27.   和根崎真大,西山悟史,平山敦士,渡邉哲,久保田功,成松宏人,深尾彰,有海躬行:     山形県急性心筋梗塞発症登録評価研究事業平成23年のまとめ.山形県医師会会報.201374213-17

 

28.   高橋徹也,近江晃樹,富樫尚子,齋藤博樹,桐林伸幸,新関武史,佐々木敏樹,金子一善,菅原重生,久保田功:第196回東北地方会(2012.6.16)推薦 今月の症例 ビタミンB1が著効した衝心脚気及びWernicke脳症の1例.日本内科学会雑誌.2013102      (7)1790-1793

 

29.   須貝孝幸伊関憲真島佑介市川一誠林田昌子久保田功急激な経過で死亡したoverwhelming postsplenectomy infection (OPSI) の一例日集中医誌201320649-650